CSS LLC/IL

Position in HIMS — Hims & Hers Health, Inc.

CIK 1103646 CHICAGO, IL

Back to HIMS Full portfolio

Position in HIMS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$780,908

+$780,908 QoQ

Shares Held

37,616

Ownership

0.016%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in HIMS Over Time

Shares Held

Position Value (USD)

Derivatives in HIMS

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$1,814,424

PutShares

87,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CSS LLC/IL holds $5,129,429 across 8 Drug Manufacturers - Specialty & Generic names. HIMS ranks #4 (15.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	2,757	$1,634,845
2	NBIX	Neurocrine Biosciences Inc	6,950	$915,593
3	TEVA	Teva Pharmaceutical Industries Ltd	27,070	$815,348
4	HIMS	Hims & Hers Health, Inc. This page	37,616	$780,908
5	ZTS	Zoetis Inc.	6,220	$735,266
6	VTRS	Viatris Inc	8,520	$115,105
7	YCBD	cbdMD, Inc.	137,621	$102,114
8	EVO	Evotec SE	12,100	$30,250

All Filings in HIMS

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,814,424	87,400	+132.3%	Put	Sole	2026-05-15
2026-03-31	$780,908	37,616	-62.3%	Shares	Sole	2026-05-15
2025-12-31	$3,243,753	99,900	+56.1%	Put	Sole	2026-02-17
2025-09-30	$3,630,080	64,000	+220.0%	Put	Sole	2025-11-13
2025-06-30	$997,000	20,000	-29.9%	Put	Sole	2025-08-14
2021-03-31	$377,293	28,518	-5.3%	Shares	Sole	2021-05-17
2021-03-31	$398,223	30,100	—	Put	Sole	2021-05-17
No filing history on record for this holder in this stock.